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Effect and Mechanism of Tamoxifen on Peritoneal Fibrosis in Mice
Undergoing Peritoneal Dialysis
Xiang Zhao
Zhejiang Province People’s Hospital, Hangzhou, Zhejiang, China
Objective: To investigate the effect and the perhaps mechanism of tamox-
ifen on peritoneal dialysis related peritoneal fibrosis.
Methods: Intraperitoneal injected with 4.25% glucose peritoneal dialysis
fluid to establish a mouse model of peritoneal fibrosis. C57BL/6 male mouse
were randomly divided into three groups: control group; high-glucose perito-
neal fluid group (PDF group), and tamoxifen group (TAX group). Histologic
changes were examined by Masson’s trichrome stain. Expression of Wnt4,
b-catenin, E-cadherin, NF-kB, COL1A1, cytokeratin protein were evaluated
by immunofluorescence staining and Western Blot.
Results: A light microscope Masson’s trichrome stain showed the peritonum
of mouse in PDF group are significantly thicker than control group; the
tamoxifen treatment ameliorated the thickening of peritoneum induced by
PDF. Immunofluorescence staining and Western Blot showed that protein
expression of Wnt4, b-catenin, NK-kB, COL1A1 increased in PDF group than
in control group (all P < 0.05), protein expression of E-cadherin and basic
cytokeratin decreased in PDF group than in control group (all P < 0.05).
The tamoxifen treatment ameliorated the increased expression of Wnt4,
b-catenin, NK-kB, COL1A1 induced by PDF and the expression of E-cadherin
and basic cytokeratin decreased than in PDF group.
Conclusion: Peritoneal dialysis related peritoneal fibrosis may mediated by
the activation of Wnt / b-catenin signaling pathway in mouse peritonum, and
tamoxifen can ameliorated peritoneal fibrosis possibly by inhibiting the Wnt
/ b-catenin signaling pathway.http://dx.doi.org/10.1016/j.hkjn.2015.09.180
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Efficacy of Low-dose Bisoprolol in Maintenance Hemodialysis Patients
with Asymptomatic Left Ventricular Diastolic Dysfunction
Wei Shen, Qiang He, Yiwen Li
Kidney Disease Center, Zhejiang Province People’s Hospital, Hangzhou,
Zhejiang, China
Objective: Left ventricular hypertrophy and diastolic dysfunction are the most
frequent cardiac alteration in ESRD. The aim of this study was to determine
whether the b-blocker, bisoprolol, has beneficial effects inmaintenance hemo-
dialysis patients with asymptomatic left ventricular diastolic dysfunction.
Methods: In this study we enrolled 120 patients with chronic kidney disease
(CKD) undergoingmaintenancehemodialysis accompanying left ventricular dia-
stolic dysfunction more than six months. Bisoprolol was started with 1.25 mg
once daily orally 30 minutes after breakfast and increased every 1 week by
1.25 mg increments up to the maximum tolerated dose. Echocardiographic ex-
amination was used to measurement of left ventricular diastolic function.
Results: 108 patients finished 6 months study. After 6 months of treatment,
compared with the baseline, the cardiothoracic ratio was significant
decreased. Echocardiographic examination showed that there was no signif-
icant change in EF, but LVDd, LVDs, PWT were significant decreased. E/A ra-
tio was significantly increased.
Conclusion: Our study demonstrate bisoprolol efficacy in improving left ven-
tricular diastolic dysfunction in HD patient with normal blood pressure.http://dx.doi.org/10.1016/j.hkjn.2015.09.1810109
Effect of Hemodialysis on Anterior Chamber Biometric Structure and
Intraocular Pressure in Non-Diabetic Patients with End-stage Renal
Disease
Wei Shen, Qiang He, Yiwen Li
Kidney Disease Center, Zhejiang Province People’s Hospital, Hangzhou,
Zhejiang, China
Objective: To evaluate the short-term changes in the ophthalmologic find-
ings after low-flux hemodialysis in non-diabetic end-stage chronic renal fail-
ure (CRF) patients.
Methods: Forty-three patients (86 eyes) selected so as not to have glaucoma or
history of glaucomawere studied. We observed the patients onmaintenance he-
modialysis therapymore than6months. Their clinical characteristics andmedical
recordsbeforeandafterhemodialysiswere reviewedthroughthewayof self-con-
trol study. Detailed ophthalmologic examinations together with tomometre
(intraocular pressure, IOP), A/B scan (lens thickness) and ultrasound bio-
microscopy (central anterior chamber depth) were performed immediately
beforeandafterHDsessions.Demographic information includingage, gender,un-
derling systemicdiseases,hemodialysisduration,and levelsofbodyweight,blood
urea nitrogen, and creatinine before and after hemodialysis were recorded.
Results: The mean age of the patients at the time of dialysis was 49.7 12.0
(range 33 to 65) years. 53.5% (23) were men. After hemodialysis treatment,
the blood urea nitrogen, creatinine, patient weight decreased significantly
(P < 0.01). There was no significant difference in the change in serum cal-
cium, serum phosphorus, serum albumin and hemoglobin after treatment
(P > 0.05). Mean central anterior chamber depth also decreased significantly
after HD, from 2.46 0.38 to 2.38 0.36 mum (paired t test, P < 0.01).
Mean lens thickness significantly increased from 4.23 0.22 mm before HD
to 4.30 0.12 mm after HD (P < 0.01) in group. However, Mean IOP
increased from 12.32 4.31 mmHg to 14.31 2.98 mmHg after HD (paired
t test, P < 0.01).
Conclusion:Conventional hemodialysis can affect the ophthalmologic findings.
Patients with chronic renal failure should be checked of their anterior chamber
structure and be given corresponding treatment before haemodialysis.http://dx.doi.org/10.1016/j.hkjn.2015.09.182
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miRNA-143/145 Gene Cluster Enhances Cell Deformation and Fibrosis of
Human Peritoneal Mesothelial Cells via Modulating TPM4
Lijie He, Jinping Hu, Tiantian Shi
Department of Nephrology, Xi’an, China
Objective: This work for the function and mechanism of miR-143/145 gene
cluster in human peritoneal mesothelial cells (HPMC).
Methods: To investigate if miR-143/145 gene cluster could promote PM
fibrosis, all these immortal and cast-off HPMCs from the effluents of
end-stage renal disease (ESRD) patients with peritoneal dialysis (PD)
were characterized by fibrosis related markers and tested the expression
of miRNA-143/145 cluster and tropomyosin 4 (TPM4) by real time PCR or
Western blot. We also used PD dialysis rat model to observe the response
of PM to miR-143/145 gene cluster and their possible target.
Results: Here, we found that miR-143/145 gene cluster, which are exam-
ined to be highly expressed in HG-induced HPMCs or in cast-off HPMCs ex
vivo which have a transformed fibroblastic phenotype stimulated by high
glucose (HG, 60 mmol/L) and in PD animal model. TPM4 were found signif-
icantly lower expression in HG-induced HPMCs. So our study showed that
high glucose from PD fluid could promote the expression of miR-143/145
of HPMCs and reduce the expression of TPM4, compared with normal
glucose-cultured HPMCs (Figure 1A-E). Reporter assays further supported
that TPM4 were post-transcriptionally regulated together by miR-143/145
gene cluster. Collectively, these data suggested that TPM4 was a down-
stream target of miR-143/145 gene cluster. Re-expression of miR-143/
145 gene cluster by miR-143 or miR-145 mimic led to cell deformation,
and reduced cell adhesion, following the down-regulating expression of
TPM4 and E-cadherin, but up-regulating expression of a-SMA, CTGF, colla-
gens and fibronectin which might increase PM fibrosis. Depletion of miR-
143/145 cluster in HG-induced HPMCs enhanced cell adhesion, marking
by up-regulating E-cadherin and TPM4 but down-regulating a-SMA, CTGF,
collagens and fibronectin in vitro (Figure 1F).
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to target the messenger RNA TPM4 to contribute to the cell adhesion, defor-
mation and fibrosis.http://dx.doi.org/10.1016/j.hkjn.2015.09.183
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Use of Femoral Vein Cuffed Tunneled Catheter for Haemodialysis
Xinxin Jiang, Qiang He, Yiwen Li, Wei Shen, Quanquan Shen, Xiaogang Shen,
Xiujun Xu
Zhejiang Provincial People’s Hospital, Hangzhou, Zhejiang, China
Objective: Although arteriovenous fistula is the best choice of vascular ac-
cess for hemodialysis, cuffed tunneled catheter widely used for hemodialysis
in the absence of arteriovenous fistula or arteriovenous graft fistula.
Indwelling a cuffed tunneled catheter in the central vein is a common
vascular access for hemodialysis. To some patients who can not lie down
due to heart failure or other reasons, catheterization through internal jugu-
lar vein may be exposed to an increased risk during catheterization proce-
dure. For these patients, catheterization through femoral vein may be a
good choice. In this study, we want to find the outcome of femoral vein cuf-
fed tunneled catheter for hemodialysis.
Methods: From April 2013 to December 2014, 32 maintained hemodialysis
patients received 34 cuffed tunneled catheters inserted through the femoral
vein. There were 15 male and 17 female patients. The patients’ mean age
was 73.46. A 45-cm-long Covidien double lumen catheter with a Dacron
cuff at 27 cm from the tip was placed in the femoral vein of each patient.
The tip of catheter was in the inferior vena cava.
Results: All procedures of femoral vein cuffed tunneled catheter implanta-
tion were technically successful. The 6-month primary patency rate was
62.8%. The 12-month primary patency rate was 51.3%. The 6-month assisted
primary patency rate was 83.5%. The 12-month assisted primary patency
rate was 62.2%. The blood flow of femoral vein catheter was 240 45 ml/
min. The mean session Kt/V was 1.37 0.36. The main complications were
1 thrombosis of femoral vein and external iliac vein, 2 stenosis of external
iliac vein, and 7 femoral vein catheter related bacteraemia (3.97 episodes
per 1000 CVC-days).
Conclusion: The femoral vein cuffed tunneled catheter could be used as a
vascular access for hemodialysis.http://dx.doi.org/10.1016/j.hkjn.2015.09.1840115
Bone Marrow-derived Macrophage-Myofibroblast Transition: A Novel
Pathway in Peritoneal Fibrosis
Jianwen Yu1,2, Xiaoru Huang2,3, Xueqing Yu2,3, Huiyao Lan2,3
1Department of Nephrology, The First Affiliated Hospital, Sun Yat-Sen
University, Guangzhou, China
2Li Ka Shing Institute of Health Sciences and Department of Medicine &
Therapeutics, The Chinese University of Hong Kong, Hong Kong, China
3Shenzhen Research Institute, The Chinese University of Hong Kong,
Shenzhen, China
Objective: Patients who undergo peritoneal dialysis (PD) often develop peri-
toneal fibrosis that is characterized by the accumulation of myofibroblasts,
but the precise origin of this fibrogenic cell type remains unknown. We
recently found that a-smooth muscle actin (a-SMA)+ myofibroblasts are co-
expressing CD68 macrophage antigen in the fibrotic peritoneum. Thus, we
hypothesized that macrophage-myofibroblast transition (MMT) may be a
novel source of myofibroblast origin during peritoneal fibrosis, which is
examined in this study.
Methods: Parietal peritoneal biopsy samples were collected from long-term
PD patients (nZ 10) and MMT cells were identified by CD68+a-SMA+ cells us-
ing two-color immunohistochemistry. LysM-Cre/Rosa26tdTomato mice were
constructed for macrophage fate mapping study in experimental PD model
induced by hyperglycemic dialysis solutions. Mechanisms of MMT were stud-
ied in vivo using Smad3 wildtype (WT) and knockout (KO) mice.
Results: Immunohistochemical study showed that a minor population of a-
SMA+ cells coexpressed CD68 in peritoneal biopsy tissues (5.08%). Immuno-
fluorescence and flow cytometry results demonstrated that > 90% CD68+
macrophages in peritoneal tissues were labeled with the tdTomato fate
marker in both control and model group. In addition, almost all tdTomato+
cells (> 99%) expressed with CD45 in model group, indicating that these
cells were recruited from bone marrow rather than resident macrophages.
Three-color confocal imaging showed that CD68+tdTomato+a-SMA+ cells
amounted to 9.39% of a-SMA+ myofibroblasts in model group and these cells
also expressed Collagen I. Compared to Smad3 WT littermates, the percent-
age of CD68+a-SMA+ cells was remarkably reduced in Smad3 KO model group
(p < 0.001).
Conclusion: Bone marrow-derived macrophages may constitute a novel
source of myofibroblasts during peritoneal fibrosis. Smad3 is required for
the MMT process.http://dx.doi.org/10.1016/j.hkjn.2015.09.185
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Relationship Among BMI, BP Control and Cardiovascular Mortality in
Incident CAPD Patients
Ricong Xu, Li Fan, Liping Xiong, Naya Huang, Zhijian Li, Xueqing Yu,
Haiping Mao
Department of Nephrology, The First Affiliated Hospital, Sun Yat-sen
University, Guangzhou, Guangdong, China
Objective: To study the relationship between body mass index (BMI) and
blood pressure (BP) control and their effect on cardiovascular mortality in
continuous ambulatory peritoneal dialysis (CAPD) patients.
Methods: We conduct a retrospective cohort study in 1144 incident CAPD
patients in our center to evaluate the association between BMI and BP con-
trol and their effect on cardiovascular mortality. The BMI was categorized
using the criteria from the Working Group on Obesity in China. Binary logis-
tic regression and the Cox’s proportional hazards regression models were
used to assess the relationship between BMI and uncontrolled BP, and the
association of BMI and uncontrolled BP with cardiovascular mortality,
respectively.
Results: The mean BMI was 21.74 3.17 kg/m2. Compared to patients with
normal weight, those with overweight were associated with an increased risk
of uncontrolled BP (OR, 1.93; 95% CI, 1.33e2.82), as well as uncontrolled SBP
(OR, 1.53; 95% CI, 1.06e2.22) in the full adjusted model. During a median
follow up of 26.6 months, 106 (9.3 %) patients died due to cardiovascular dis-
ease. Uncontrolled SBP was associated 96% higher risks of cardiovascular
death in adjusted model (OR, 1.96; 95% CI, 1.09e3.54). Although there
was no significant interaction between BMI and uncontrolled BP, individuals
with concurrent underweight and uncontrolled BP (HR, 3.07; 95% CI,
1.10e8.53), as well as underweight and uncontrolled SBP (HR, 4.60; 95%
